Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Compare long-run outcomes for index versus active strategies, emphasizing time horizons, persistence of outperformance, and practical takeaways.
27,723 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Kalshi has closed two insider trading investigations tied to a former California gubernatorial candidate and a mrbeas...
Rigetti Computing releases Q4 2025 results after hours, showing revenue near 2.3 million and a continued loss as it a...
Oil-driven volatility keeps the S&P 500 near unchanged on March 11, 2026, as traders weigh supply risks and central-b...
XRP’s open interest has plunged to a level last seen before a major rally, raising questions about a potential reboun...
When a member of a royal family steps into the public eye after a major news cycle, personal finances can feel the pr...
Bitcoin climbs past $80,000 on renewed ETF demand and institutional buying. Analysts map potential paths for BTC and ...
Bitcoin Suisse has secured Bermuda regulatory licenses to operate regulated digital asset management and investment a...
The musician sheryl crow selling a 2.2-acre slice from her Nashville estate for $1.8 million highlights growing liqui...
A utilities-focused ETF has delivered defensive resilience through several recessions this century, as AI demand and ...
A Google software engineer is facing insider trading charges after allegedly using confidential internal data to prof...
Over the last decade, Taiwan Semiconductor has posted a blistering 2,095% return, turning a $1,000 stake into about $...